Cargando…
Risk factors of secondary cancer in nasopharyngeal carcinoma patients after radiotherapy
Purpose: To identify risk factors of secondary cancer in nasopharyngeal carcinoma (NPC) patients after radiotherapy. Materials and methods: The data of NPC patients with secondary cancer were extracted from the Surveillance, Epidemiology, and End Results database from 2004 to 2016. Univariate and mu...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608213/ https://www.ncbi.nlm.nih.gov/pubmed/36313032 http://dx.doi.org/10.7150/jca.77768 |
_version_ | 1784818725752406016 |
---|---|
author | Wang, Wen-Jie Li, Miao Pan, Xin-Bin |
author_facet | Wang, Wen-Jie Li, Miao Pan, Xin-Bin |
author_sort | Wang, Wen-Jie |
collection | PubMed |
description | Purpose: To identify risk factors of secondary cancer in nasopharyngeal carcinoma (NPC) patients after radiotherapy. Materials and methods: The data of NPC patients with secondary cancer were extracted from the Surveillance, Epidemiology, and End Results database from 2004 to 2016. Univariate and multivariate logistic regression analysis was performed to identify risk factors of secondary cancer. Risk factors selected from the multivariable logistic regression analysis were used to build a predicting model. Results: A total of 3931 patients were included: 329 (8.37%) patients developed secondary cancers and 3602 (91.63%) patients did not have secondary cancers. Univariate logistic regression analysis revealed that age, race, and the American Joint Committee on Cancer (AJCC) stage were risk factors of secondary cancer. Multivariable analysis demonstrated that age [Odds ratio (OR) = 1.03, P < 0.001], race (OR = 1.17, P = 0.010), AJCC stage (OR = 0.82, P = 0.002), and chemotherapy (OR = 1.55, P = 0.028) were independent risk factors of secondary cancer. Age, race, AJCC stage, and chemotherapy were entered into a nomogram for predicting secondary cancer. The area under the ROC curve of the nomogram was 0.645 [95% confidence interval (CI): 0.617-0.673]. The decision curve showed that if the threshold probability is between 4% and 25%, using the nomogram added more benefit than either the treat-all-patients scheme or the treat-none scheme. Conclusion: Age, race, AJCC stage, and chemotherapy were independent risk factors of secondary cancer in nasopharyngeal carcinoma patients after radiotherapy. |
format | Online Article Text |
id | pubmed-9608213 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-96082132022-10-27 Risk factors of secondary cancer in nasopharyngeal carcinoma patients after radiotherapy Wang, Wen-Jie Li, Miao Pan, Xin-Bin J Cancer Research Paper Purpose: To identify risk factors of secondary cancer in nasopharyngeal carcinoma (NPC) patients after radiotherapy. Materials and methods: The data of NPC patients with secondary cancer were extracted from the Surveillance, Epidemiology, and End Results database from 2004 to 2016. Univariate and multivariate logistic regression analysis was performed to identify risk factors of secondary cancer. Risk factors selected from the multivariable logistic regression analysis were used to build a predicting model. Results: A total of 3931 patients were included: 329 (8.37%) patients developed secondary cancers and 3602 (91.63%) patients did not have secondary cancers. Univariate logistic regression analysis revealed that age, race, and the American Joint Committee on Cancer (AJCC) stage were risk factors of secondary cancer. Multivariable analysis demonstrated that age [Odds ratio (OR) = 1.03, P < 0.001], race (OR = 1.17, P = 0.010), AJCC stage (OR = 0.82, P = 0.002), and chemotherapy (OR = 1.55, P = 0.028) were independent risk factors of secondary cancer. Age, race, AJCC stage, and chemotherapy were entered into a nomogram for predicting secondary cancer. The area under the ROC curve of the nomogram was 0.645 [95% confidence interval (CI): 0.617-0.673]. The decision curve showed that if the threshold probability is between 4% and 25%, using the nomogram added more benefit than either the treat-all-patients scheme or the treat-none scheme. Conclusion: Age, race, AJCC stage, and chemotherapy were independent risk factors of secondary cancer in nasopharyngeal carcinoma patients after radiotherapy. Ivyspring International Publisher 2022-10-09 /pmc/articles/PMC9608213/ /pubmed/36313032 http://dx.doi.org/10.7150/jca.77768 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Wang, Wen-Jie Li, Miao Pan, Xin-Bin Risk factors of secondary cancer in nasopharyngeal carcinoma patients after radiotherapy |
title | Risk factors of secondary cancer in nasopharyngeal carcinoma patients after radiotherapy |
title_full | Risk factors of secondary cancer in nasopharyngeal carcinoma patients after radiotherapy |
title_fullStr | Risk factors of secondary cancer in nasopharyngeal carcinoma patients after radiotherapy |
title_full_unstemmed | Risk factors of secondary cancer in nasopharyngeal carcinoma patients after radiotherapy |
title_short | Risk factors of secondary cancer in nasopharyngeal carcinoma patients after radiotherapy |
title_sort | risk factors of secondary cancer in nasopharyngeal carcinoma patients after radiotherapy |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608213/ https://www.ncbi.nlm.nih.gov/pubmed/36313032 http://dx.doi.org/10.7150/jca.77768 |
work_keys_str_mv | AT wangwenjie riskfactorsofsecondarycancerinnasopharyngealcarcinomapatientsafterradiotherapy AT limiao riskfactorsofsecondarycancerinnasopharyngealcarcinomapatientsafterradiotherapy AT panxinbin riskfactorsofsecondarycancerinnasopharyngealcarcinomapatientsafterradiotherapy |